Bio-Gene Technology Ltd. (AU:BGT) has released an update.
Bio-Gene Technology Ltd. is advancing towards the regulatory approval of Flavocide®, a nature-derived insecticidal active ingredient, with positive feedback from the Australian Pesticides and Veterinary Medicines Authority (APVMA). The company is on schedule to submit the regulatory dossier by the end of 2025, following APVMA’s guidance on the required studies for its application, ensuring the development path is optimized. Flavocide promises to be a significant advancement in combating insecticide resistance in various sectors, including public health, agriculture, and consumer use.
For further insights into AU:BGT stock, check out TipRanks’ Stock Analysis page.